Takeda Pharmaceutical Company Limited
TKPHF is fairly valued
OTC · Healthcare
FAIR PRICE
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
$35.89
MARKET PRICE
$37.94
FAIR PRICE
$2.05
MARGIN
COMMUNITY BUY ZONE
UNLOCKS AT 10
Where does the market buy TKPHF?
No one has priced TKPHF yet — be the first. Every investor sets the maximum price they'd still buy at; together that maps the community buy zone.
COMMUNITY MEDIAN
▓▓▓▓▓
BUYERS AT TODAY'S PRICE
▓▓ %
0/10 INVESTORS · 10 MORE TO UNLOCK
METRICS
NOW AVAILABLE
Get notified when TKPHF's fair price changes
Push notifications when TKPHF's valuation shifts. Available on iOS and Android.
FPI RATING
Attractive valuation, but below-average fundamental quality.
Analytical data, not an investment recommendation. Updated daily.
How we calculate this ↗MARGIN OF SAFETY
A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.
SAFETY MARGIN
20%
Below fair value
ENTRY LEVEL
$30.35
Fair price × 0.80
DISTANCE
15.4%
Price to entry level
At the current price of $35.89, TKPHF trades 15.4% above the conservative entry level of $30.35. This entry level represents a 20% margin of safety below the calculated fair price of $37.94 — a buffer that accounts for estimation uncertainty in the valuation model.
Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗
VALUATION HISTORY
SYNCING FEED ▌
P/E RATIO HISTORY
SYNCING FEED ▌
METHODOLOGY
How we calculate TKPHF's fair price
Takeda Pharmaceutical Company Limited's fair price of $37.94 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $35.89, TKPHF trades 5.7% below its calculated fair value.
DCF MODEL · 50%
Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting TKPHF's risk profile.
RELATIVE · 30%
Comparing TKPHF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.
ANALYST · 20%
Aggregated analyst price targets for TKPHF, weighted by recency and analyst accuracy.
TRY IT YOURSELF
Want to test your own assumptions? Use our free calculators to estimate TKPHF's fair value with your own inputs.
TKPHF DCF Calculator
Pre-filled with TKPHF's real free cash flow and share count — set your own growth and discount rate to calculate intrinsic value.
Graham Number
Enter TKPHF's EPS and book value to see the maximum price Benjamin Graham would pay for this stock.
P/E Ratio Calculator
Check how much investors pay per dollar of TKPHF's earnings and compare it against sector benchmarks.
EV/EBITDA Calculator
Compare TKPHF against peers on a debt-adjusted basis using enterprise value and EBITDA.
LEARN MORE
POWERED BY BULIOS
Get full analysis, financials, and AI insights for TKPHF.
Explore on BuliosFAQ
What is the fair price of TKPHF?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Takeda Pharmaceutical Company Limited is $37.94. At the current market price of $35.89, TKPHF trades 5.7% below its calculated fair value.
Is TKPHF overvalued or undervalued?+
Takeda Pharmaceutical Company Limited is currently fair based on our valuation model. The stock trades at $35.89, which is 5.7% below the fair price of $37.94. The P/E ratio of 273.5x is a key metric in the valuation.
What is the margin of safety for TKPHF?+
With a 20% margin of safety applied to the fair price of $37.94, the conservative entry level for TKPHF is $30.35. At the current market price of $35.89, the stock trades 15.4% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.
How often is TKPHF's fair price updated?+
We update fair price calculations for TKPHF daily after market close. The current fair price of $37.94 incorporates the latest market data and sector multiples.
What factors affect TKPHF's fair price calculation?+
TKPHF's fair price of $37.94 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 273.5x, ROE of 0.5%, and dividend yield of 7.24%.
Is TKPHF a good buy right now?+
At $35.89, TKPHF trades 5.7% below our fair value estimate of $37.94. The stock is currently fair. ROE stands at 0.5% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does TKPHF pay dividends?+
TKPHF has a dividend yield of 7.24%.
RELATED STOCKS
Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.